Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome

Kidney Int Rep. 2024 Aug 26;9(11):3332-3334. doi: 10.1016/j.ekir.2024.08.021. eCollection 2024 Nov.

¹ Translational Transplant Research Center (TTRC) and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Nephrology, Dialysis, and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
³ Department of Experimental Medicine, University of Genoa, Genoa, Italy.

No abstract available

Keywords: glomerulonephritis; nephrotic syndrome; rituximab.